Chesley Taft & Associates’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-29,575
| Closed | -$135K | – | 259 |
|
|
2015
Q3 | $135K | Sell |
29,575
-12,500
| -30% | -$57.1K | 0.01% | 220 |
|
|
2015
Q2 | $218K | Buy |
42,075
+10,775
| +34% | +$55.8K | 0.02% | 218 |
|
|
2015
Q1 | $196K | Sell |
31,300
-1,200
| -4% | -$7.51K | 0.02% | 232 |
|
|
2014
Q4 | $204K | Sell |
32,500
-750
| -2% | -$4.71K | 0.02% | 235 |
|
|
2014
Q3 | $202K | Buy |
33,250
+10,400
| +46% | +$63.2K | 0.02% | 238 |
|
|
2014
Q2 | $151K | Sell |
22,850
-223,700
| -91% | -$1.48M | 0.02% | 245 |
|
|
2014
Q1 | $5.87M | Buy |
246,550
+22,000
| +10% | +$524K | 0.63% | 58 |
|
|
2013
Q4 | $2.4M | Buy |
224,550
+99,700
| +80% | +$1.06M | 0.24% | 108 |
|
|
2013
Q3 | $1.66M | Buy |
124,850
+22,850
| +22% | +$305K | 0.18% | 122 |
|
|
2013
Q2 | $1.34M | Buy |
+102,000
| New | +$1.34M | 0.16% | 133 |
|